Francisco Arvelo

ORCID: 0000-0003-1590-358X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Research Studies
  • Cancer therapeutics and mechanisms
  • Bioactive Natural Diterpenoids Research
  • Neuroendocrine Tumor Research Advances
  • Cancer Cells and Metastasis
  • Cancer Research and Treatments
  • Synthesis and biological activity
  • Synthesis and Biological Evaluation
  • Essential Oils and Antimicrobial Activity
  • Insect Pest Control Strategies
  • Traditional and Medicinal Uses of Annonaceae
  • Research on Leishmaniasis Studies
  • Drug Transport and Resistance Mechanisms
  • Glycosylation and Glycoproteins Research
  • Cancer, Hypoxia, and Metabolism
  • Peptidase Inhibition and Analysis
  • Trypanosoma species research and implications
  • Biological Activity of Diterpenoids and Biflavonoids
  • Ion Channels and Receptors
  • Alkaloids: synthesis and pharmacology
  • Cell death mechanisms and regulation
  • Cancer-related Molecular Pathways
  • Genetic factors in colorectal cancer
  • Cancer, Lipids, and Metabolism
  • Synthesis and Characterization of Heterocyclic Compounds

Central University of Venezuela
2013-2024

Instituto de Estudios Avanzados
2015-2024

Colciencias
2020

Institut Curie
1993-2004

Centre National de la Recherche Scientifique
1993-2003

Institut Gustave Roussy
1993-1996

Laboratoire d'études sur les monothéismes
1992

Abstract Transcription factors are crucial to an understanding of the molecular basis neoplasia. Horneobox‐containing genes a family transcriptional regulators encoding DNA‐binding ho‐meodomains, involved in control normal development. Class‐1 human homeobox‐containing ( HOX genes) display peculiar chromosomal organization, perhaps directly related their function. Aberrant expression homeobox‐genes has been associated with both morphological abnormalities and oncogenesis. We have recently...

10.1002/ijc.2910580426 article EN International Journal of Cancer 1994-08-15

Two series of 17 tetrahydroquinoline compounds (2,4-DAr-THQs and DSQs), in which the 4-methoxy-3- hydroxyphenyl (isovanillin) structural unit is incorporated, were tested for their potential human tumor cell growth inhibitory effect on MCF-7, SKBR-3, PC3, HeLa non-tumor cells (primary culture dermis fibroblast – control cells) first time. The THQ 8 an interesting model antitumoral drugs, displaying cytotoxic activity against MCF7, SKBR3 or PC3 (IC50 7.99 - 16.14 μM) with selectivity index...

10.2174/157018010792929577 article EN Letters in Drug Design & Discovery 2010-09-30

Background: Patients with small-cell lung carcinomas (SCLCs) initially respond to combination chemotherapy. Only a few benefit in terms of long-term survival because most relapse. Such outcome may be attributable development multi-drug resistance. Purpose : The response SCLC chemotherapy was examined ( ) patient survival, b drug sensitivity tumors patients and tumor xenografts nude mice, c expression multidrug resistance gene MDR1 GST-π gene. Methods Tumor samples obtained from seven...

10.1093/jnci/85.24.2023 article EN JNCI Journal of the National Cancer Institute 1993-12-01

Analysis of the dichloromethane extract aerial parts Croton cuneatus led to isolation new glutarimide alkaloids: julocrotol (1), isojulocrotol (2), and julocrotone (3) along with known compounds julocrotonine (4), lichexanthone (5) selin-11-en-4α-ol (6). The structures were established by spectral methods. in vitro cytotoxic activity Compounds 1–6 was evaluated against six human tumor cells lines.

10.1080/14786410310001622004 article EN Natural Product Research 2004-06-07

Prediction of human tumor response based on preclinical data could reduce the failure rates subsequent new anticancer drugs clinical development. Human small-cell lung carcinomas (SCLC) are characterized by high initial sensitivity to chemotherapy but a low median survival time because drug resistance. The aim this study was evaluate therapeutic relevance panel SCLC xenografts established in our laboratory using one compromising SCLC, topotecan (TPT). Six derived from six patients were used:...

10.1097/cad.0b013e3283300a29 article EN Anti-Cancer Drugs 2009-12-04

11-Deoxyfistularin-3 (1), a new bromotyrosine derivative, was isolated among other known compounds such as fistularin-3 (2), aerothionin (3), and 11-oxoaerothionin (4) from the Caribbean sponge Aplysinafistularis (Aplysinellidae). The structure of 1 determined by spectroscopic analysis showed in vitro activity against human breast carcinoma cell line MCF-7.

10.1021/np9901938 article EN Journal of Natural Products 1999-09-03

1 Faculty of Science, Institute Food Science and Technology, Central University Venezuela, Postal code 1041-A, zip 47097, Caracas, Venezuela. 2 Pharmacy, Laboratory Natural Products, 3 Experimental Biology, 4 Foundation for Advanced Studies, IDEA,

10.9734/bjast/2015/13587 article EN British Journal of Applied Science & Technology 2014-11-11

Many theories mention hypersensitive, promiscuous, outlaw or bypass signalling pathways to explain the acquisition of hormone independence in prostate cancer. Hormonal escape tumours is marked by many biological changes, including mucinous and neuroendocrine differentiation. Since expression several mucins has been linked carcinoma tumour progression, we have characterised at both RNA protein levels an vivo model cancer hormonal escape. Using PAC120, a xenograft human hormone-dependent...

10.1038/sj.bjc.6601570 article EN cc-by-nc-sa British Journal of Cancer 2004-02-01
Coming Soon ...